{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T21:57:30Z","timestamp":1764194250317},"reference-count":59,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.endinu.2017.06.006","type":"journal-article","created":{"date-parts":[[2017,10,10]],"date-time":"2017-10-10T23:45:35Z","timestamp":1507679135000},"page":"498-505","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Secuelas endocrinol\u00f3gicas en supervivientes de c\u00e1ncer infantil"],"prefix":"10.1016","volume":"64","author":[{"given":"Paula","family":"Casano Sancho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.endinu.2017.06.006_bib0300","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.endinu.2017.06.006_bib0305","series-title":"Registro Espa\u00f1ol de Tumores Infantiles (RETI-SEHOP)","article-title":"C\u00e1ncer infantil en Espa\u00f1a. Estad\u00edsticas 1980-2015","author":"Peris","year":"2016"},{"key":"10.1016\/j.endinu.2017.06.006_bib0310","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1001\/jama.2013.6296","article-title":"Clinical ascertainment of health outcomes among adults treated for childhood cancer","volume":"309","author":"Hudson","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.endinu.2017.06.006_bib0315","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1056\/NEJMsa060185","article-title":"Chronic health conditions in adult survivors of childhood cancer","volume":"355","author":"Oeffinger","year":"2006","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.endinu.2017.06.006_bib0320","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1056\/NEJMoa1510795","article-title":"Reduction in Late Mortality among 5-Year Survivors of Childhood Cancer","volume":"374","author":"Armstrong","year":"2016","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.endinu.2017.06.006_bib0325","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ejpn.2015.07.011","article-title":"Strategies to improve the quality of survival for childhood brain tumour survivors","volume":"19","author":"Tallen","year":"2015","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.endinu.2017.06.006_bib0330","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1016\/S0140-6736(14)60114-8","article-title":"Childhood cancer, endocrine disorders, and cohort studies","author":"Oeffinger","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.endinu.2017.06.006_bib0335","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/S0140-6736(13)62564-7","article-title":"Hospital contacts for endocrine disorders in Adult Life after Childhood Cancer in Scandinavia (ALiCCS): a population-based cohort study","volume":"383","author":"De Fine Licht","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.endinu.2017.06.006_bib0340","unstructured":"Children's Oncology Group Long-Term Follow-Up Guidelines.Version 4.0 survivorshipguidelines.org Disponible en: http:\/\/www.survivorshipguidelines.org\/pdf\/COG_LTFU Guidelines."},{"issue":"3","key":"10.1016\/j.endinu.2017.06.006_bib0345","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1210\/jc.2011-2104","article-title":"Endocrine health problems detected in 519 patients evaluated in a pediatric cancer survivor program","volume":"97","author":"Patterson","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"suppl 2","key":"10.1016\/j.endinu.2017.06.006_bib0350","first-page":"116","article-title":"Implementation of endocrine follow up in a Childhood Cancer Survivor Unit","volume":"76","author":"Casano \u2013Sancho","year":"2011","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.endinu.2017.06.006_bib0355","first-page":"65","article-title":"Endocrine late effects of childhood cancer therapy: A report from the Children's Oncology Group","volume":"69","author":"Nandagopal","year":"2008","journal-title":"Horm Res"},{"issue":"2","key":"10.1016\/j.endinu.2017.06.006_bib0360","first-page":"53","article-title":"Growth hormone response to a growth hormone-releasing hormone stimulation test in a population-based study following cranial irradiation of childhood brain tumors","volume":"54","author":"Schmiegelow","year":"2000","journal-title":"Horm Res"},{"issue":"6","key":"10.1016\/j.endinu.2017.06.006_bib0365","doi-asserted-by":"crossref","first-page":"891","DOI":"10.4158\/EP10391.OR","article-title":"Pituitary hormone dysfunction after proton beam radiation therapy in children with brain tumors","volume":"17","author":"Viswanathan","year":"2011","journal-title":"Endocr Pract"},{"issue":"9","key":"10.1016\/j.endinu.2017.06.006_bib0370","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1002\/1097-0142(19851101)56:9<2189::AID-CNCR2820560909>3.0.CO;2-I","article-title":"Long-term effects of cranial irradiation on endocrine function in children with brain tumors. A prospective study","volume":"56","author":"Duffner","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.endinu.2017.06.006_bib0375","doi-asserted-by":"crossref","first-page":"4776","DOI":"10.1200\/JCO.2011.37.9453","article-title":"Growth hormone secretion after conformal radiation therapy in pediatric patients with localized brain tumors","volume":"29","author":"Merchant","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.endinu.2017.06.006_bib0380","doi-asserted-by":"crossref","unstructured":"Growth Hormone Research Society. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. GH Research Society. J Clin Endocrinol Metab 2000; 85:3990-3.","DOI":"10.1210\/jc.85.11.3990"},{"key":"10.1016\/j.endinu.2017.06.006_bib0385","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1210\/jc.2013-4159","article-title":"Growth hormone exposure as a risk factor for the development of subsequent neoplasms of the central nervous system: a report from the Childhood Cancer Survivor Study","volume":"99","author":"Patterson","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endinu.2017.06.006_bib0390","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1093\/jnci\/djj411","article-title":"New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study","volume":"98","author":"Neglia","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.endinu.2017.06.006_bib0395","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1067\/S0022-3476(03)00246-4","article-title":"Update of guidelines for the use of growth hormone in children: the Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee","volume":"143","author":"Wilson","year":"2003","journal-title":"J Pediatr"},{"issue":"8","key":"10.1016\/j.endinu.2017.06.006_bib0400","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1210\/jc.2003-030366","article-title":"Improvements in final height over 25 years in growth hormone (GH)-deficient childhood survivors of brain tumors receiving GH replacement","volume":"88","author":"Gleeson","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endinu.2017.06.006_bib0405","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1210\/jc.2003-031224","article-title":"Reassessemnt of growth hormone status is required at final height in children treated with growth hormone replacement after raditation therapy","volume":"89","author":"Gleeson","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endinu.2017.06.006_bib0410","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fendo.2013.00064","article-title":"Adult growth hormone deficiency - benefits, side effects, and risks of growth hormone replacement","volume":"4","author":"Reed","year":"2013","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.endinu.2017.06.006_bib0415","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1530\/EJE-12-1043","article-title":"Endocrine health conditions in adult survivors of childhood cancer: the need for specialized adult-focused follow-up clinics","volume":"168","author":"Steffens","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endinu.2017.06.006_bib0420","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1046\/j.1365-2265.2001.01169.x","article-title":"An audit of 500 subcutaneous glucagon stimulation test to assess growth hormone and ACTH secretion in patients with hypothalamic-pituitary disease","volume":"54","author":"Leong","year":"2001","journal-title":"Clinical Endocrinol"},{"key":"10.1016\/j.endinu.2017.06.006_bib0425","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1210\/jc.2002-021994","article-title":"Assessment of the hypothalamo-pituitary-adrenal axis in patients treated with radiotherapy and chemotherapy for childhood brain tumor","volume":"88","author":"Schmiegelow","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.endinu.2017.06.006_bib0430","first-page":"4472","article-title":"Diagnosis of hidden central hypothyroidism in survivors of childhood cancer","volume":"84","author":"Rose","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endinu.2017.06.006_bib0435","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000207616","article-title":"Alterations in pubertal timing following therapy for childhood malignancies","volume":"15","author":"Armstrong","year":"2009","journal-title":"Endocr Dev"},{"key":"10.1016\/j.endinu.2017.06.006_bib0440","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1200\/JCO.2011.38.6938","article-title":"Male reproductive health after childhood, adolescent, and young adult cancers: a report from the Children's Oncology Group","volume":"30","author":"Kenney","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.endinu.2017.06.006_bib0445","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1210\/jcem.83.9.5121","article-title":"Serum inhibin B as a marker of spermatogenesis","volume":"83","author":"Pierik","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endinu.2017.06.006_bib0450","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/088800100276415","article-title":"Male gonadal function in survivors of childhood Hodgkin and non-Hodgkin lymphoma","volume":"17","author":"Ben Arush","year":"2000","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.endinu.2017.06.006_bib0455","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1093\/humrep\/dem313","article-title":"Inhibin B is superior to FSH as a serum marker for spermatogenesis in men treated for Hodgkin's lymphoma with chemotherapy during childhood","volume":"22","author":"Van Beek","year":"2007","journal-title":"Hum Reprod"},{"issue":"10","key":"10.1016\/j.endinu.2017.06.006_bib0460","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1200\/JCO.2012.43.7038","article-title":"Lack of specificity of plasma concentrations of inhibin B and follicle-stimulating hormone for identification of azoospermic survivors of childhood cancer: a report from the St Jude lifetime cohort study","volume":"31","author":"Green","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.endinu.2017.06.006_bib0465","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/0360-3016(90)90007-7","article-title":"Gonadal status and reproductive function following treatment for Hodgkin's disease in childhood: the Stanford experience","volume":"19","author":"Ortin","year":"1990","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.endinu.2017.06.006_bib0470","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/humrep\/den487","article-title":"Assessment of ovarian reserve in adult childhood cancer survivors using anti-M\u00fcllerian hormone","volume":"24","author":"Lie Fong","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.endinu.2017.06.006_bib0475","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/humrep\/dem392","article-title":"Anti-m\u00fcllerian hormone as a marker of ovarian function in women after chemotherapy and radiotherapy for haematological malignancies","volume":"23","author":"Lie Fong","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.endinu.2017.06.006_bib0480","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jpag.2016.04.009","article-title":"Anti-m\u00fcllerian hormone in female adolescent cancer patients before, during, and after completion of therapy: A pilot feasibility study","volume":"29","author":"Gupta","year":"2016","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"28","key":"10.1016\/j.endinu.2017.06.006_bib0485","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1200\/JCO.2015.64.3288","volume":"34","author":"Van Dorp","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.endinu.2017.06.006_bib0490","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jpeds.2012.12.037","article-title":"Longitudinal linear growth and final height is impaired in childhood acute lymphoblastic leukemia survivors after treatment without cranial irradiation","volume":"163","author":"Vandecruys","year":"2013","journal-title":"J Pediatr"},{"key":"10.1016\/j.endinu.2017.06.006_bib0495","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1002\/ijc.24581","article-title":"Risk of thyroid cancer in survivors of childhood cancer: results from the British Childhood Cancer Survivor Study","volume":"125","author":"Taylor","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.endinu.2017.06.006_bib0500","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ejca.2015.12.006","article-title":"Ultrasound surveillance for radiation-induced thyroid carcinoma in adult survivors of childhood cancer","volume":"55","author":"Brignardello","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.endinu.2017.06.006_bib0505","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/cncr.28463","article-title":"Comparison of secondary and primary thyroid cancer in adolescents and young adults","volume":"120","author":"Goldfarb","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.endinu.2017.06.006_bib0510","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ctrv.2014.10.009","article-title":"Is outcome of differentiated thyroid carcinoma influenced by tumor stage at diagnosis?","volume":"41","author":"Clement","year":"2015","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.endinu.2017.06.006_bib0515","doi-asserted-by":"crossref","first-page":"468","DOI":"10.4158\/EP.16.3.468","article-title":"American Association of Clinical Endocrinologists,Associazione Medici Endocrinologi, and European Thyroid Association Medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: executive summary of recommendations","volume":"16","author":"Gharib","year":"2010","journal-title":"Endocr Pract"},{"key":"10.1016\/j.endinu.2017.06.006_bib0520","doi-asserted-by":"crossref","unstructured":"American Thyroid Association (ATA) Guidelines Taskforce on thyroid nodules and differentiated thyroid cancer. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009; 19:1167-214.","DOI":"10.1089\/thy.2009.0110"},{"key":"10.1016\/j.endinu.2017.06.006_bib0525","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1200\/JCO.2011.38.6938","article-title":"Male reproductive health after childhood, adolescent, and young adult cancers: a report from the Children's Oncology Group","volume":"20","author":"Kenney","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.endinu.2017.06.006_bib0530","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1200\/JCO.1993.11.1.100","article-title":"Efficacy and toxicity of multiagent chemotherapy and low-dose involved-field radiotherapy in children and adolescents with Hodgkin's disease","volume":"11","author":"Hudson","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.endinu.2017.06.006_bib0535","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.bbmt.2016.01.023","article-title":"Late effect surveillance recommendations among survivors of childhood hematopoietic cell transplantation: A Children's Oncology Group Report","volume":"22","author":"Chow","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1016\/j.endinu.2017.06.006_bib0540","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1210\/jc.2012-4075","article-title":"Endocrine side effects induced by immune checkpoint inhibitors","volume":"98","author":"Corsello","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.endinu.2017.06.006_bib0545","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1210\/jc.2012-4085","article-title":"Clinical review: kinase inhibitors: adverse effects related to the endocrine system","volume":"98","author":"Lodish","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endinu.2017.06.006_bib0550","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1089\/thy.2013.0241","article-title":"Thyroid dysfunction as an unintended side effect of anticancer drugs","volume":"23","author":"Torino","year":"2013","journal-title":"Thyroid"},{"key":"10.1016\/j.endinu.2017.06.006_bib0555","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1742-1241.2008.01856.x","article-title":"Is there any relationship between imatinib mesylate medication and hypothalamic-pituitary-adrenal axis dysfunction?","volume":"64","author":"Bilgir","year":"2010","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.endinu.2017.06.006_bib0560","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EJE-12-0167","article-title":"Ipilimumab: a novel immunomodulating therapy causing autoimmune hypophysitis: a case report and review","volume":"167","author":"Juszczak","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endinu.2017.06.006_bib0565","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1002\/pbc.24397","article-title":"Growth failure in children with chronic myeloid leukemia receiving imatinib is due to disruption of GH\/IGF-1 axis","volume":"60","author":"Narayanan","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.endinu.2017.06.006_bib0570","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.bone.2011.04.014","article-title":"The skeletal effects of the tyrosine kinase inhibitor nilotinib","volume":"49","author":"O'Sullivan","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.endinu.2017.06.006_bib0575","doi-asserted-by":"crossref","first-page":"e705","DOI":"10.1542\/peds.2007-1396","article-title":"Bone mineral density deficits in survivors of childhood cancer: long-term follow-up guidelines and review of the literature","volume":"121","author":"Wasilewski-Masker","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.endinu.2017.06.006_bib0580","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/pbc.25010","article-title":"Bone mineral density among long-term survivors of childhood acute lymphoblastic leukemia: results from the St. Jude Lifetime Cohort Study","volume":"61","author":"Gurney","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.endinu.2017.06.006_bib0585","doi-asserted-by":"crossref","first-page":"4639","DOI":"10.1200\/JCO.2008.16.3527","article-title":"Longitudinal changes in obesity and body mass index among adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study","volume":"26","author":"Garmey","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.endinu.2017.06.006_bib0590","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s12672-016-0274-1","article-title":"Development of metabolic syndrome associated to cancer therapy: Review","volume":"7","author":"Casco","year":"2016","journal-title":"Horm Cancer"}],"container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530016417301891?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530016417301891?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T22:53:52Z","timestamp":1636239232000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2530016417301891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":59,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S2530016417301891"],"URL":"https:\/\/doi.org\/10.1016\/j.endinu.2017.06.006","relation":{},"ISSN":["2530-0164"],"issn-type":[{"value":"2530-0164","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Secuelas endocrinol\u00f3gicas en supervivientes de c\u00e1ncer infantil","name":"articletitle","label":"Article Title"},{"value":"Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.endinu.2017.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 SEEN y SED. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}